This checklist is designed to guide biotechs in selecting CROs and endpoint vendors for oncology trials. It provides structured considerations across vendor experience, scientific expertise, regulatory knowledge, operational support, and global readiness. The document emphasizes minimizing participant burden, reducing change orders, and ensuring access to senior scientific teams. Dedicated sections address clinical adjudication, eCOA and connected devices, imaging, and cardiac safety, with detailed questions to evaluate vendor capabilities. Oncology-specific needs such as tumor response criteria, imaging workflows, QT requirements, blood pressure guidance, and at-home data collection are highlighted. The checklist serves as a practical decision-making tool to help sponsors optimize data qu

Join for free to read